TMO
Ticker
Thermo Fisher Scientific Inc
Company
LifeSciences
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
4.6%9.4%8.2%4.6%29.0%0.4%7.7%14.5%16.4%4.9%26.1%21.7%14.5%-4.6%0.1% 3.2%
Revenue Growth QoQ
Gross Margin
39.8%40.7%41.5%42.3%42.2%44.4%45.7%45.8%45.2%44.6%44.4%49.7%50.1%42.2%39.9%41.3% 41.3%
EBITDA Margin
18.2%18.5%18.3%19.7%19.9%24.8%23.7%23.0%23.9%24.8%26.9%31.4%32.2%26.2%24.0%24.4% 23.6%
Operating Margin
10.4%11.4%10.8%11.8%12.3%14.8%13.8%13.4%14.2%15.5%18.0%24.2%25.6%18.7%16.0%17.1% 17.2%
Profit Margin
8.4%9.8%11.5%9.4%9.7%11.2%11.6%11.1%10.6%12.1%14.5%19.8%19.7%15.5%14.0%14.8% 15.0%
FCF / EBITDA
79.1%63.5%67.8%69.9%66.2%52.3%59.5%66.9%70.0%62.6%58.9%67.3%53.8%58.7%67.5%69.6% 59.3%